Advertising

NASDAQ:KRTX

103.02
2.58 (2.57%) 1d
0
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »
COMMENT
An early-stage biopharma, so you can't buy their drugs right now, but they are developing drugs. Their lead drug treats schizophrenia as well as psychosis. Shares are up 21% YTD, but has pulled back hard in the past month.
Pharma & Healthcare
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

Karuna Therapeutics(KRTX-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Karuna Therapeutics is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Karuna Therapeutics(KRTX-Q) Frequently Asked Questions

What is Karuna Therapeutics stock symbol?

Karuna Therapeutics is a American stock, trading under the symbol KRTX-Q on the NASDAQ (KRTX). It is usually referred to as NASDAQ:KRTX or KRTX-Q

Is Karuna Therapeutics a buy or a sell?

In the last year, there was no coverage of Karuna Therapeutics published on Stockchase.

Is Karuna Therapeutics a good investment or a top pick?

Karuna Therapeutics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Karuna Therapeutics.

Why is Karuna Therapeutics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Karuna Therapeutics worth watching?

In the last year 0 stock analysts on Stockchase covered Karuna Therapeutics. The stock is worth watching.

What is Karuna Therapeutics stock price?

On 2022-05-19, Karuna Therapeutics (KRTX-Q) stock closed at a price of $103.02.